Immunitybio, Inc.
IBRX
Revenue
26.43M
▲9.91M▲59.99%
3 Months ChangeAssets
402.08M
▲98.32M▲32.37%
3 Months ChangeLiabilities
971.90M
▲77.65M▲8.68%
3 Months ChangeFree Cash Flow
-87.03M
▲21.22M▲19.60%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-12
Form 10-Q
ID: 0001326110-24-000103
2024-07-18
Form 8-K
ID: 0001326110-24-000093
2024-06-12
Form 8-K
ID: 0001326110-24-000069
2024-05-09
Form 10-Q
ID: 0001326110-24-000064
2024-04-23
Form 8-K
ID: 0001326110-24-000040
2024-02-26
Form 8-K
ID: 0001193125-24-044886
2024-01-02
Form 8-K
ID: 0001326110-24-000003
2023-11-09
Form 10-Q
ID: 0001326110-23-000147
2023-09-11
Form 8-K
ID: 0001326110-23-000121
2023-09-01
Form 8-K
ID: 0001326110-23-000112